The presentation:

a) will provide attendees with an overview of some of the hurdles that manufacturers need to consider before they can bring their specialty medication to market, ensuring that patients who need the medication can get access and,

b) explain how Innomar has become a market leader using a patient-centric approach when working with manufacturers and, of course, patients.

Ron will also address some of the challenges that Innomar faces from a patient support program (PSP) perspective. 


We suggest